Cargando…
CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972440/ http://dx.doi.org/10.1016/S0735-1097(22)03147-3 |
_version_ | 1784679839210405888 |
---|---|
author | Vu, Michael Canela, Victor Prathivada, Sri Naga Pavani Abualfoul, Mujahed Zhao, Yi Hoang, Lawrence M. Wang, Lucas Sidhu, Manavjot Singh |
author_facet | Vu, Michael Canela, Victor Prathivada, Sri Naga Pavani Abualfoul, Mujahed Zhao, Yi Hoang, Lawrence M. Wang, Lucas Sidhu, Manavjot Singh |
author_sort | Vu, Michael |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8972440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American College of Cardiology Foundation. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89724402022-04-01 CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN Vu, Michael Canela, Victor Prathivada, Sri Naga Pavani Abualfoul, Mujahed Zhao, Yi Hoang, Lawrence M. Wang, Lucas Sidhu, Manavjot Singh J Am Coll Cardiol Spotlight on Special Topics American College of Cardiology Foundation. Published by Elsevier Inc. 2022-03-08 2022-04-01 /pmc/articles/PMC8972440/ http://dx.doi.org/10.1016/S0735-1097(22)03147-3 Text en © 2022 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Spotlight on Special Topics Vu, Michael Canela, Victor Prathivada, Sri Naga Pavani Abualfoul, Mujahed Zhao, Yi Hoang, Lawrence M. Wang, Lucas Sidhu, Manavjot Singh CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN |
title | CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN |
title_full | CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN |
title_fullStr | CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN |
title_full_unstemmed | CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN |
title_short | CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN |
title_sort | critically ill covid-19 patients and therapeutic anticoagulation with heparin |
topic | Spotlight on Special Topics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972440/ http://dx.doi.org/10.1016/S0735-1097(22)03147-3 |
work_keys_str_mv | AT vumichael criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin AT canelavictor criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin AT prathivadasrinagapavani criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin AT abualfoulmujahed criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin AT zhaoyi criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin AT hoanglawrencem criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin AT wanglucas criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin AT sidhumanavjotsingh criticallyillcovid19patientsandtherapeuticanticoagulationwithheparin |